Overview:

Neonatal (Preterm) infant care forms a significant part of the pediatric healthcare market in the U.S. as Neonatal (Preterm) births are one of the leading causes of infant mortality in the country. One in every eight births in the U.S. are Neonatal (Preterm), and the condition is on an alarming rise due to factors such as induced fertility, labor treatments, poor prenatal care, inappropriate maternal age, obesity, and smoking. Neonatal (Preterm) infant care products (equipment, drugs, and formulae) can thus be life-critical as they provide the respiratory, nutritional, and thermal support necessary for the survival of pre-term babies. The vital role of these products in Neonatal (Preterm) infant care thus forms the major factor driving market growth.

Market Estimates and Forecasts
In addition to market data on the submarkets of the U.S. Neonatal (Preterm) infant care market, each section of the report will identify and analyze the market trends, opportunities, and the factors driving or inhibiting market growth. The report will also draw a competitive landscape, in which it will profile the top 35 market players. The report categorizes the U.S. Neonatal (Preterm) Infant Care market as follows:

Neonatal (Preterm) Infant Care Equipment (Diagnosis, therapy, and monitoring)
Neonatal (Preterm) Infant Formula (For use in hospitals, after discharge, iron fortified cow’s milk formulas, hydrolyzed whey based formulas, casein hydrolysate formulas, amino acid formulas)
Neonatal (Preterm) Infant Care Drugs (Antibiotics, bronchodilators, analgesics, diuretics, vassopressors, hematologic agents)
Neonatal (Preterm) Infant Care Services Market (Diagnosis, therapy, and monitoring)

What makes our reports unique?

We provide the longest market segmentation chain in this industry- not many reports provide market breakdown upto level 5.
We provide 10% customization. Normally it is seen that clients do not find specific market intelligence that they are looking for. Our customization will ensure that you necessarily get the market intelligence you are looking for and we get a loyal customer.
We conduct detailed market positioning, product positioning and competitive positioning. Entry strategies, gaps and opportunities are identified for all the stakeholders.

Comprehensive market analysis for the following sectors :
Pharmaceuticals, Medical Devices, Biotechnology, Semiconductor and Electronics, Energy and Power Supplies, Food and Beverages, Chemicals, Advanced Materials, Industrial Automation, and Telecom and IT. We also analyze retailers and super-retailers, technology providers, and research and development (R&D) companies.

Key questions answered

Which are the high-growth segments/cash cows and how is the market segmented in terms of devices, infant formula, drugs, services?
What are market estimates and forecasts; which markets are doing well and which are not?
Where are the gaps and opportunities; what is driving the market?
Which are the key playing fields? Which are the winning edge imperatives?
How is the competitive outlook; who are the main players in each of the segments; what are the key selling products; what are their strategic directives, operational strengths and product pipelines? Who is doing what?

Powerful Research and analysis

The analysts working with MarketsandMarkets come from renowned publishers and market research firms, globally, adding their expertise and domain understanding. We get the facts from over 22,000 news and information sources, a huge database of key industry participants and draw on our relationships with more than 900 market research companies across the world. We, at MarketsandMarkets, are inspired to help our clients grow by providing qualitative business insights with our huge market intelligence repository.

1 INTRODUCTION
1.1KEY TAKE AWAYS
1.2REPORT DESCRIPTION
1.3MARKET ESTIMATES AND FORECASTS
1.4STAKEHOLDERS
1.5RESEARCH METHODOLOGY

2 SUMMARY

3 MARKET OVERVIEW
3.1SOCIOECONOMIC IMPACT & COST ANALYSIS
3.2DRIVERS
3.2.1INCREASING INCIDENCE OF Neonatal (Preterm) BIRTHS
3.2.1.1Inappropriate maternal age
3.2.1.2Induced fertility treatments
3.2.1.3Genetic predisposition
3.2.1.4Lack of awareness and inadequate prenatal care
3.2.1.5Obesity, diabetes, smoking
3.2.2AVAILABILITY OF LOW-COST EQUIPMENT
3.2.3GOVERNMENT INITIATIVES
3.3RESTRAINTS & OPPORTUNITIES
3.3.1HIGH ENTRY BARRIERS
3.3.2NOVEL TRENDS IN INFANT FORMULAE
3.3.3TECHNOLOGY DEVELOPMENTS
3.4NOVEL APPROACHES TO Neonatal (Preterm) INFANT CARE
3.4.1DEVELOPMENTAL CARE
3.4.2NEONATAL INFORMATION SYSTEMS
3.5KEY FINDINGS

4 Neonatal (Preterm) INFANT CARE SERVICES MARKET
4.1OVERVIEW
4.2THERAPY & MONITORING SERVICES
4.3DIAGNOSIS

5 U.S. Neonatal (Preterm) INFANT CARE, PRODUCTS MARKET
5.1OVERVIEW
5.2DELIVERY SYSTEMS
5.2.1DRIVERS
5.2.1.1Integral part of Neonatal (Preterm) babies treatment
5.2.1.2Replacement units & price differentiation generating revenues
5.2.2RESTRAINTS
5.2.2.1Lack of technology differentiation
5.2.2.2Low priced devices
5.2.3OPPORTUNITY
5.2.3.1Systems addressing pain management
5.2.4FEEDING TUBES
5.2.5INTRAVENOUS LINES
5.2.6UMBILICAL CATHETER
5.2.7PERIPHERALLY INSERTED CENTRAL CATHETER LINE
5.3BILI LIGHTS
5.4RESPIRATORY ASSISTANCE DEVICES
5.4.1DRIVERS
5.4.1.1Life saving devices
5.4.1.2Large number of babies suffering from respiratory distress syndrome
5.4.1.3Changing technologies
5.4.2RESTRAINTS
5.4.2.1Life threatening harmful effects of some devices
5.4.2.2Low cost ventilators
5.4.2.3Opportunities
5.4.2.3.1Software solutions make the device user friendly
5.4.2.3.2Home care devices
5.5THERMAL CONTROL EQUIPMENTS
5.5.1DRIVERS
5.5.1.1Life saving portable and versatile equipment
5.5.1.2Portable and versatile systems
5.5.2RESTRAINT
5.5.2.1Low cost
5.5.3OPPORTUNITY
5.5.3.1Scope for structural improvements
5.6MONITORING DEVICES
5.6.1DRIVERS
5.6.1.1Novel IT solutions
5.6.1.2Non invasive techniques & point-of-care analyzers
5.6.1.2.1Increasing demand for reliable patient data
5.6.1.2.2Necessity of the devices in early detection of abnormality
5.6.2RESTRAINTS
5.6.2.1Cost reductions
5.6.3OPPORTUNITY
5.6.3.1Expanded use of microprocessing technology
5.6.3.2Lab-on-chip monitoring devices
5.6.3.3Nanobarcodes and RFID
5.7DIAGNOSTIC EQUIPMENT
5.7.1DRIVERS
5.7.1.1Technology advances enhancing consumption
5.7.2RESTRAINTS
5.7.2.1Requires high investments
5.7.2.2Inadequate clinical trials of the devices
5.7.3OPPORTUNITY
5.7.3.1Nano enabled devices & integration of nanotech and IT
5.7.4IMAGING EQUIPMENT
5.8PRE TERM INFANT FORMULA
5.9CHANGING TRENDS IN THE Neonatal (Preterm) INFANT FORMULA INDUSTRY
5.10Neonatal (Preterm) FORMULAS FOR USE IN HOSPITALS
5.11Neonatal (Preterm) FOLLOW-UP FORMULAS AFTER DISCHARGE
5.12DRUGS

6 COMPETITIVE LANDSCAPE
6.1OVERVIEW

7 GEOGRAPHIC ANALYSIS
7.1OVERVIEW
7.2OPPORTUNITIES
7.3MISSISSIPPI
7.3.1QUICK FACTS
7.3.2RISK FACTOR ANALYSIS
7.4ALABAMA
7.4.1QUICK FACTS
7.4.2RISK FACTOR ANALYSIS
7.5DISTRICT OF COLUMBIA
7.5.1QUICK FACTS
7.5.2RISK FACTOR ANALYSIS
7.6LOUISIANA
7.6.1QUICK FACTS
7.6.2RISK FACTOR ANALYSIS
7.7KENTUCKY
7.7.1QUICK FACTS
7.7.2RISK FACTOR ANALYSIS
7.8SOUTH CAROLINA
7.8.1RISK FACTOR ANALYSIS
7.9TENNESSEE
7.9.1RISK FACTOR ANALYSIS
7.10NEVADA
7.10.1RISK FACTOR ANALYSIS
7.11NEW MEXICO
7.11.1RISK FACTOR ANALYSIS
7.12GEORGIA
7.12.1RISK FACTOR ANALYSIS
7.13WEST VIRGINIA
7.13.1RISK FACTOR ANALYSIS
7.14OKLAHOMA
7.14.1RISK FACTOR ANALYSIS
7.15FLORIDA
7.15.1RISK FACTOR ANALYSIS
7.16TEXAS
7.16.1RISK FACTOR ANALYSIS
7.17ARKANSAS
7.17.1RISK FACTOR ANALYSIS
7.18CALIFORNIA
7.18.1RISK FACTOR ANALYSIS
7.19NEW YORK
7.19.1RISK FACTOR ANALYSIS
7.20OHIO
7.20.1RISK FACTOR ANALYSIS
7.21ILLINOIS
7.21.1RISK FACTOR ANALYSIS
7.22PENNSYLVANIA
7.22.1RISK FACTOR ANALYSIS

8 PATENT ANALYSIS
8.1PATENT ANALYSIS BY ASSIGNEE
8.2PATENT ANALYSIS BY PRODUCTS
8.3PATENT ANALYSIS BY EQUIPMENT

9 COMPANY PROFILES
9.1ABBOTT NUTRITION
9.2ANALOGIC CORP
9.3ATOM MEDICAL INTERNATIONAL CORP.
9.4ARJOHUNTLEIGH
9.5CAREFUSION INC
9.6CAS MEDICAL SYSTEMS INC
9.7CHILDREN'S HOSPITAL OF PHILADELPHIA
9.8CHILDREN'S NATIONAL MEDICAL CENTER
9.9CLINICAL INNOVATIONS
9.10COVIDIEN LTD.
9.11CRITICARE SYSTEMS, INC.
9.12DRAEGERWERK AG & CO. KGAA
9.13EDAN INSTRUMENTS, INC
9.14FISHER & PAYKEL HEALTHCARE CORP.
9.15FUKUDA DENSHI CO. LTD.
9.16GE HEALTHCARE
9.17HAMILTON MEDICAL AG
9.18KCBIOMEDIX, INC
9.19MASIMO CORP.
9.20MEAD JOHNSON NUTRITION CO
9.21MEDELA INC.
9.22MEDIX I.C.S.A
9.23NATUS MEDICAL INC.
9.24NESTLE NUTRITION
9.25NEWYORK-PRESBYTERIAN MORGAN STANLEY CHILDREN'S HOSPITAL
9.26NIHON KOHDEN CORP.
9.27NONIN MEDICAL INC.
9.28ORIDION SYSTEMS LTD
9.29PEDIATRIX MEDICAL GROUP
9.30PHOENIX MEDICAL SYSTEMS PVT LTD
9.31PHILIPS RESPIRONICS INC
9.32SPACELABS MEDICAL, INC
9.33UTAH MEDICAL PRODUCTS, INC.
9.34WELCH ALLYN INC.
9.35WYETH NUTRITION CORP

APPENDIX
PATENTS
 
LIST OF TABLES

SUMMARY TABLE U.S. Neonatal (Preterm) INFANT CARE MARKET 2007 – 2014 ($MILLIONS)
TABLE 1U.S. Neonatal (Preterm) INFANT CARE MARKET, BY SEGMENT  2007 – 2014 ($MILLIONS)
TABLE 2U.S. Neonatal (Preterm) INFANT CARE SERVICES MARKET, 2007 – 2014 ($MILLIONS)
TABLE 3U.S. Neonatal (Preterm) INFANT CARE EQUIPMENT MARKET, BY PRODUCTS 2007 – 2014 ($MILLIONS)
TABLE 4  U.S. Neonatal (Preterm) INFANT CARE THERAPY & MONITORING EQUIPMENT MARKET, 2007 – 2014 ($MILLIONS)
TABLE 5  PREMATURE DIAGNOSTIC DEVICES
TABLE 6  THERMAL CONTROL DEVICES
TABLE 7 MONITORING DEVICES
TABLE 8  DIAGNOSTIC EQUIPMENT
TABLE 9U.S. Neonatal (Preterm) INFANT FORMULA MARKET, BY PRODUCTS 2007 – 2014 ($MILLIONS)
TABLE 10AGREEMENTS AND COLLABORATIONS IN THE Neonatal (Preterm) INFANT CARE MARKET (2007-2009)
TABLE 11NEW PRODUCT LAUNCHES IN THE Neonatal (Preterm) INFANT CARE MARKET (2007-2009)
TABLE 12MERGERS AND ACQUISITIONS IN THE Neonatal (Preterm) INFANT CARE MARKET (2006-2009)
TABLE 13  Neonatal (Preterm) BIRTH RATE IN ETHNICITIES - MISSISSIPPI
TABLE 14  Neonatal (Preterm) BIRTH RATE IN ETHNICITIES - ALABAMA
TABLE 15  Neonatal (Preterm) BIRTH RATE IN ETHNICITIES - DISTRICT OF COLUMBIA
TABLE 16  Neonatal (Preterm) BIRTH RATE IN ETHNICITIES - LOUISIANA
TABLE 17  Neonatal (Preterm) BIRTH RATE IN ETHNICITIES - KENTUCKY
TABLE 18  Neonatal (Preterm) BIRTH RATE IN ETHNICITIES - SOUTH CAROLINA
TABLE 19  Neonatal (Preterm) BIRTH RATE IN ETHNICITIES - TENNESSEE
TABLE 20  Neonatal (Preterm) BIRTH RATE IN ETHNICITIES - NEVADA
TABLE 21  Neonatal (Preterm) BIRTH RATE IN ETHNICITIES - NEW MEXICO
TABLE 22  Neonatal (Preterm) BIRTH RATE IN ETHNICITIES - GEORGIA
TABLE 23  Neonatal (Preterm) BIRTH RATE IN ETHNICITIES - WEST VIRGINIA
TABLE 24  Neonatal (Preterm) BIRTH RATE IN ETHNICITIES - OKLAHOMA
TABLE 25  Neonatal (Preterm) BIRTH RATE IN ETHNICITIES - FLORIDA
TABLE 26  Neonatal (Preterm) BIRTH RATE IN ETHNICITIES - TEXAS
TABLE 27  Neonatal (Preterm) BIRTH RATE IN ETHNICITIES - ARKANSAS
TABLE 28  Neonatal (Preterm) BIRTH RATE IN ETHNICITIES - CALIFORNIA
TABLE 29  Neonatal (Preterm) BIRTH RATE IN ETHNICITIES - NEW YORK
TABLE 30  Neonatal (Preterm) BIRTH RATE IN ETHNICITIES - OHIO
TABLE 31  Neonatal (Preterm) BIRTH RATE IN ETHNICITIES - ILLINOIS
TABLE 32  Neonatal (Preterm) BIRTH RATE IN ETHNICITIES - PENNSYLVANIA

LIST OF FIGURES

FIGURE 1 CURRENT Neonatal (Preterm) BIRTH RATE IN THE U.S
FIGURE 2  SOCIOECONOMIC COSTS
FIGURE 3  INCREASING RATES Neonatal (Preterm) BIRTHS IN THE U.S.
FIGURE 4  PROMINENT RISK FACTORS CAUSING Neonatal (Preterm) BIRTHS
FIGURE 5  DEVELOPMENTAL CARE
FIGURE 6UTILIZATION RATES OF RESPIRATORY ASSISTANCE DEVICES IN Neonatal (Preterm) INFANT CARE
FIGURE 7TECHNOLOGY TRENDS IN THE RESPIRATORY ASSISTANCE DEVICES MARKET
FIGURE 8PERCENT UTILIZATION RATES OF THERMAL CONTROL EQUIPMENT
FIGURE 9TECHNOLOGY TRENDS IN THE MONITORING DEVICES MARKET
FIGURE 10TECHNOLOGY DEVELOPMENT IN THE DIAGNOSTIC EQUIPMENT MARKET
FIGURE 11UTILIZATION RATES OF DIAGNOSTIC EQUIPMENT IN Neonatal (Preterm) INFANT CARE
FIGURE 12PRODUCT DEVELOPMENT IN THENeonatal (Preterm) INFANT CARE MARKET
FIGURE 13PRODUCT DEVELOPMENTS IN MEDICAL DEVICES
FIGURE 14NEW PRODUCT LAUNCHES
FIGURE 15AGREEMENTS AND COLLABORATIONS
FIGURE 16Neonatal (Preterm) BIRTH RATES, BY STATES
FIGURE 17PATENT ANALYSIS, BY ASSIGNEE (2000 – 2009)
FIGURE 18PATENTS ANALYSIS, BY PRODUCTS (2000 – 2009)
FIGURE 19PATENTS ANALYSIS, BY EQUIPMENT (2000 – 2009)
FIGURE 20PATENT ANALYSIS, BY THERAPY & MONITORING EQUIPMENT (2000 – 2009)